文献速递慢性肾脏病

与慢性肾脏病进展相关的新遗传变异

Novel Genetic Variants Associated with Chronic Kidney Disease Progression.
PubMed 文献 · J Am Soc Nephrol · 2023-01-05

该研究在1738例慢性肾脏病患者中开展全基因组关联研究,以eGFR斜率为结局,并在2498例患者中复制,发现TPPP和FAT1-LINC02374两个新位点的单核苷酸多态性与eGFR下降相关,基于22个独立显著单核苷酸多态性构建的多基因风险评分与慢性肾脏病结局显著相关。

要点

  • TPPP位点rs59402340与eGFR斜率相关(发现阶段P=7.11×10⁻⁷,CRIC复制P=8.13×10⁻⁴,Meta分析P=7.23×10⁻⁸)。
  • FAT1-LINC02374位点rs28629773与eGFR斜率相关(发现阶段P=6.08×10⁻⁷,CRIC复制P=4.33×10⁻²,Meta分析P=1.87×10⁻⁷)。
  • 基于22个独立显著顶级单核苷酸多态性构建的多基因风险评分与慢性肾脏病结局显著相关。

核心结论

  • TPPP和FAT1-LINC02374位点的单核苷酸多态性标志物可能作为慢性肾脏病患者eGFR下降的预测标志物。

研究设计与样本

  • 两阶段全基因组关联研究,发现阶段纳入1738例慢性肾脏病患者(主要来自韩国慢性肾脏病患者结局队列研究),复制阶段纳入2498例慢性肾脏病患者(来自慢性肾功能不全队列研究)。
  • 结局为eGFR斜率。

主要发现

  • TPPP位点rs59402340与eGFR斜率相关:发现阶段P=7.11×10⁻⁷,CRIC复制P=8.13×10⁻⁴,Meta分析P=7.23×10⁻⁸。
  • FAT1-LINC02374位点rs28629773与eGFR斜率相关:发现阶段P=6.08×10⁻⁷,CRIC复制P=4.33×10⁻²,Meta分析P=1.87×10⁻⁷。
  • 表达数量性状位点研究显示复制的单核苷酸多态性调控附近与肾功能相关基因的表达水平。
  • 这些单核苷酸多态性位于基因增强子区域附近,并预测会破坏转录因子的结合。
  • 基于22个独立显著顶级单核苷酸多态性构建的多基因风险评分与慢性肾脏病结局显著相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

SIGNIFICANCE STATEMENT: eGFR slope has been used as a surrogate outcome for progression of CKD. However, genetic markers associated with eGFR slope among patients with CKD were unknown. We aimed to identify genetic susceptibility loci associated with eGFR slope. A two-phase genome-wide association study identified single nucleotide polymorphisms (SNPs) in TPPP and FAT1-LINC02374 , and 22 of them were used to derive polygenic risk scores that mark the decline of eGFR by disrupting binding of nearby transcription factors. This work is the first to identify the impact of TPPP and FAT1-LINC02374 on CKD progression, providing predictive markers for the decline of eGFR in patients with CKD. BACKGROUND: The incidence of CKD is associated with genetic factors. However, genetic markers associated with the progression of CKD have not been fully elucidated. METHODS: We conducted a genome-wide association study among 1738 patients with CKD, mainly from the KoreaN cohort study for Outcomes in patients With CKD. The outcome was eGFR slope. We performed a replication study for discovered single nucleotide polymorphisms (SNPs) with P <10 -6 in 2498 patients with CKD from the Chronic Renal Insufficiency Cohort study. Several expression quantitative trait loci (eQTL) studies, pathway enrichment analyses, exploration of epigenetic architecture, and predicting disruption of transcription factor (TF) binding sites explored potential biological implications of the loci. We developed and evaluated the effect of polygenic risk scores (PRS) on incident CKD outcomes. RESULTS: SNPs in two novel loci, TPPP and FAT1-LINC02374 , were replicated (rs59402340 in TPPP , Pdiscovery =7.11×10 -7 , PCRIC =8.13×10 -4 , Pmeta =7.23×10 -8 ; rs28629773 in FAT1-LINC02374 , Pdiscovery =6.08×10 -7 , PCRIC =4.33×10 -2 , Pmeta =1.87×10 -7 ). The eQTL studies revealed that the replicated SNPs regulated the expression level of nearby genes associated with kidney function. Furthermore, these SNPs were near gene enhancer regions and predicted to disrupt the binding of TFs. PRS based on the independently significant top 22 SNPs were significantly associated with CKD outcomes. CONCLUSIONS: This study demonstrates that SNP markers in the TPPP and FAT1-LINC02374 loci could be predictive markers for the decline of eGFR in patients with CKD.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Han M, Moon S, Lee S, et al. Novel Genetic Variants Associated with Chronic Kidney Disease Progression. J Am Soc Nephrol. 2023. PMID: 36720675. doi:10.1681/ASN.0000000000000066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。